Post-marketing withdrawal of anti-obesity medicinal products because of adverse drug reactions: a systematic review.
<h4>Background</h4> <p>We identified anti-obesity medications withdrawn since 1950 because of adverse drug reactions after regulatory approval, and examined the evidence used to support such withdrawals, investigated the mechanisms of the adverse reactions, and explored the trends...
Những tác giả chính: | Onakpoya, I, Heneghan, C, Aronson, J |
---|---|
Định dạng: | Journal article |
Ngôn ngữ: | English |
Được phát hành: |
BioMed Central
2016
|
Những quyển sách tương tự
-
Post-marketing withdrawal of analgesic medications because of adverse drug reactions: a systematic review
Bằng: Onakpoya, I, et al.
Được phát hành: (2017) -
Post-marketing withdrawal of 462 medicinal products because of adverse drug reactions: a systematic review of the world literature
Bằng: Onakpoya, IJ, et al.
Được phát hành: (2016) -
Worldwide withdrawal of medicinal products because of adverse drug reactions: a systematic review and analysis
Bằng: Onakpoya, I, et al.
Được phát hành: (2016) -
Correction to: Post-marketing withdrawal of 462 medicinal products because of adverse drug reactions: a systematic review of the world literature
Bằng: Igho J. Onakpoya, et al.
Được phát hành: (2019-03-01) -
Postmarketing withdrawal of human medicinal products because of adverse reactions in animals: a systematic review and analysis.
Bằng: Onakpoya, I, et al.
Được phát hành: (2017)